ClinicalTrials.Veeva

Menu

Whole Brain Vessel Wall Imaging in Stroke Patients (WISP): An International Multi-Center Registry

Cedars-Sinai Medical Center logo

Cedars-Sinai Medical Center

Status

Unknown

Conditions

Ischemic Stroke

Treatments

Device: MRI

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a new vessel wall imaging-based stroke registry which will investigate the clinical utility of the whole-brain intracranial vessel wall Magnetic Resonance Imaging (MRI) technique in assessing the etiologies in patients with ischemic stroke.

Full description

The registry will focus on investigating the utility of whole-brain vessel wall MRI techniques in assessing the etiologies in patients with recent ischemic stroke. Patients who have had ischemic stroke (as confirmed by diffusion weighted MRI) and have had or will undergo 3D whole-brain vessel wall MRI within 8 weeks of symptom onset will be recruited into this study. It is anticipated that a total of 1000 subjects will be recruited from Feb 2017 to Feb 2019. Approximately 12 centers in the US and China will participate in the registry. MRI whole-brain vessel wall images will be analyzed for detection and characteristics of various vessel wall pathologies and association between vessel wall imaging findings and patient's clinical information.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female ≥ 18 years of age
  • Ischemic stroke onset within 8 weeks and confirmed by diffusion weighted MRI
  • Ability to read and understand informed consent

Exclusion criteria

  • The cause of stroke has been confirmed to be related to cardiac or extracranial carotid or aorta pathologies.
  • Contraindications to MR imaging including mechanically, magnetically, or electrically activated implants, ferromagnetic implants and ferromagnetic foreign bodies, pregnancy.
  • Inability to tolerate MRI imaging secondary to an inability to lie supine or severe claustrophobia.
  • Non-compliant with visit instructions, including inability to lie still, hold breath or follow procedure instructions

Trial contacts and locations

12

Loading...

Central trial contact

Qi Yang, MD, PhD; Zhaoyang Fan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems